ArticleHaematologica2023

Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study.

Michael Launspach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.